Oncology
Conference Coverage
‘Exciting’ results for cancer vaccine plus pembro in melanoma
A new randomized study is the first to demonstrate improvement in recurrence-free survival in melanoma with an individualized neoantigen vaccine...
Conference Coverage
Racial disparities in cardiotoxicity after chemotherapy
“The most important message is to look at preexisting cardiovascular disease, oncology diagnosis, and be aware of existing disparities in a...
From the Journals
Breast cancer screening advice ‘dangerous’ for black women
The current “one-size-fits-all” policy to screen the entire female population from a certain age may be “neither fair and equitable nor optimal...
Conference Coverage
African ancestry genetically linked to worse CRC outcomes
Results from a new study provide greater clarity regarding the genetic piece of the puzzle.
Conference Coverage
AI predicts endometrial cancer recurrence
Model uses only digitized histopathology slides, but more validation in other populations is needed.
Conference Coverage
Circulating DNA has promise for cancer detection, but faces challenges
Unnecessary procedures and health care challenges could leave Whites as the primary beneficiaries.
Latest News
USPSTF releases updated recommendations on skin cancer screening
“Our recommendations are for patients who present to primary care without symptoms, and after a careful assessment of benefit and harms, we didn’t...
Latest News
Study suggests narrow excision margins safe in early melanoma resection
There were no significant differences in 10-year local recurrence rates or melanoma-specific mortality following excision with 5 mm vs. 10 mm...
Latest News
What happens to melanocytic nevi during laser hair removal?
“It’s important to keep an eye out for changes and always be evaluating,” Dr. Ahuva Cices said.
Latest News
Cancer, heart disease vaccines may be ready by 2030, Moderna says
The announcement is yet another sign of what many are calling “the golden age” of vaccine development.
Opinion
A 50-year-old White male presented with a 4- to 5-year history of progressively growing violaceous lesions on his left lower extremity
A 50-year-old presented with a 4- to 5-year history of progressively growing violaceous lesions on his left lower extremity, unresponsive to over-...